When designing TRIs, it is important to obtain an optimal relative inhibition of SERT, NET and DAT to avoid main side effects such as hypertension (high NET inhibition) or motor stimulation and stereotypies as well as abuse liability (excessive DAT blockade). Here, SLC6A3 is linked to Hypertension.